Luger A - Search Results

1

Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.

Kotzmann H, Riedl M, Pietschmann P, Schmidt A, Schuster E, Kreuzer S, Kainberger F, Frisch H, Geyer G, Hörl WH, Mayer G, Luger A. Kotzmann H, et al. Among authors: luger a. J Nephrol. 2004 Jan-Feb;17(1):87-94. J Nephrol. 2004. PMID: 15151263 Clinical Trial.

2

One-year growth hormone therapy improves granulocyte function without major effects on nutritional and anthropometric parameters in malnourished hemodialysis patients.

Kotzmann H, Schmidt A, Lercher P, Schuster E, Geyer G, Frisch H, Hörl WH, Mayer G, Luger A. Kotzmann H, et al. Among authors: luger a. Nephron Clin Pract. 2003;93(2):C75-82. doi: 10.1159/000068524. Nephron Clin Pract. 2003. PMID: 12616034 Clinical Trial.

3

Normal regulation of elevated plasma ghrelin concentrations in dialysis patients.

Schmidt A, Fabrizii V, Maier C, Riedl M, Schmidt A, Kotzmann H, Geyer G, Luger A. Schmidt A, et al. Among authors: luger a. Wien Klin Wochenschr. 2004 Apr 30;116(7-8):235-9. doi: 10.1007/BF03041053. Wien Klin Wochenschr. 2004. PMID: 15143862

4

Changes in osteopontin and in biomarkers of bone turnover during human endotoxemia.

Grimm G, Vila G, Bieglmayer C, Riedl M, Luger A, Clodi M. Grimm G, et al. Among authors: luger a. Bone. 2010 Aug;47(2):388-91. doi: 10.1016/j.bone.2010.04.602. Epub 2010 Apr 24. Bone. 2010. PMID: 20420943 Clinical Trial.

5

Sexual hormone abnormalities in male patients with renal failure.

Schmidt A, Luger A, Hörl WH. Schmidt A, et al. Among authors: luger a. Nephrol Dial Transplant. 2002 Mar;17(3):368-71. doi: 10.1093/ndt/17.3.368. Nephrol Dial Transplant. 2002. PMID: 11865078 Review. No abstract available.

6

The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans.

Maier C, Schaller G, Buranyi B, Nowotny P, Geyer G, Wolzt M, Luger A. Maier C, et al. Among authors: luger a. J Clin Endocrinol Metab. 2004 Sep;89(9):4729-33. doi: 10.1210/jc.2004-0656. J Clin Endocrinol Metab. 2004. PMID: 15356087 Clinical Trial.

7

Long term control of hypercortisolism with fluconazole: case report and in vitro studies.

Riedl M, Maier C, Zettinig G, Nowotny P, Schima W, Luger A. Riedl M, et al. Among authors: luger a. Eur J Endocrinol. 2006 Apr;154(4):519-24. doi: 10.1530/eje.1.02120. Eur J Endocrinol. 2006. PMID: 16556713

8

The relationship between insulin resistance and the cardiovascular biomarker growth differentiation factor-15 in obese patients.

Vila G, Riedl M, Anderwald C, Resl M, Handisurya A, Clodi M, Prager G, Ludvik B, Krebs M, Luger A. Vila G, et al. Among authors: luger a. Clin Chem. 2011 Feb;57(2):309-16. doi: 10.1373/clinchem.2010.153726. Epub 2010 Dec 16. Clin Chem. 2011. PMID: 21164037

9

Acute effects of hydrocortisone on the metabolic response to a glucose load: increase in the first-phase insulin secretion.

Vila G, Krebs M, Riedl M, Baumgartner-Parzer SM, Clodi M, Maier C, Pacini G, Luger A. Vila G, et al. Among authors: luger a. Eur J Endocrinol. 2010 Aug;163(2):225-31. doi: 10.1530/EJE-10-0282. Epub 2010 May 18. Eur J Endocrinol. 2010. PMID: 20484150 Clinical Trial.

10

Plasma osteopontin increases after bariatric surgery and correlates with markers of bone turnover but not with insulin resistance.

Riedl M, Vila G, Maier C, Handisurya A, Shakeri-Manesch S, Prager G, Wagner O, Kautzky-Willer A, Ludvik B, Clodi M, Luger A. Riedl M, et al. Among authors: luger a. J Clin Endocrinol Metab. 2008 Jun;93(6):2307-12. doi: 10.1210/jc.2007-2383. Epub 2008 Mar 11. J Clin Endocrinol Metab. 2008. PMID: 18334587 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

611 results

Search Page

Filters